Michael Johnson

Background

About Michael Johnson

Highly experienced leader and innovator with a focus on the successful commercialisation of emerging technologies. Since joining Rhinomed Michael has been responsible for the development of Rhinomed’s nasal technology platform and has led Rhinomed to being one of the world’s leading developers of wearable nasal medical technology. The company has successfully commercialised six products including solutions in the global sleep, snoring and respiratory markets. More recently, and in response to the global pandemic, Michael led the development of the revolutionary new Rhinoswab and Rhinoswab Junior - the world's first nasal swab designed specifically for children. Over the course of his career he has worked for large multinationals through to start-ups and across sectors- from Life Sciences, Cleantech, Financial Services and the Media and Communication industries. Michael is the lead author of over 50 patents and has coauthored research in the Journal of Clinical Psychiatry on Sleep and Suicide. Michael has received a Master’s in Entrepreneurship and Innovation from Swinburne University and a Bachelor’s degree in Business from Monash University. Michael is a non-executive director of the US based Foundation for Airway Health.